Philippe Genne

743 total citations
30 papers, 632 citations indexed

About

Philippe Genne is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Philippe Genne has authored 30 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Philippe Genne's work include Cancer therapeutics and mechanisms (11 papers), Drug Transport and Resistance Mechanisms (9 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Philippe Genne is often cited by papers focused on Cancer therapeutics and mechanisms (11 papers), Drug Transport and Resistance Mechanisms (9 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Philippe Genne collaborates with scholars based in France, United States and Switzerland. Philippe Genne's co-authors include Bruno Chauffert, Marie‐Thérèse Dimanche‐Boitrel, Éric Solary, Olivier Duchamp, Yves Pommier, Laurence Dubrez, François Goldwasser, Pierre Canal, H Pelletier and C Ardiet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and British Journal of Cancer.

In The Last Decade

Philippe Genne

30 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Genne France 15 368 262 66 54 52 30 632
Linda R. Barone United States 9 298 0.8× 242 0.9× 33 0.5× 29 0.5× 56 1.1× 12 639
K H Cowan United States 10 515 1.4× 291 1.1× 30 0.5× 46 0.9× 104 2.0× 18 792
Yue-Li Sun China 10 248 0.7× 230 0.9× 42 0.6× 38 0.7× 70 1.3× 23 535
Clifford Sachs United States 13 359 1.0× 277 1.1× 171 2.6× 25 0.5× 36 0.7× 20 720
Svein A. Carlsen Canada 15 449 1.2× 300 1.1× 117 1.8× 51 0.9× 107 2.1× 27 723
Lee R. Tanzer United States 14 473 1.3× 464 1.8× 37 0.6× 28 0.5× 86 1.7× 21 856
Gary L. Goldberg United States 17 416 1.1× 303 1.2× 81 1.2× 29 0.5× 108 2.1× 33 867
Sakkaraiappan Ramalingam United States 12 376 1.0× 334 1.3× 53 0.8× 39 0.7× 90 1.7× 30 909
Hisanobu Niitani Japan 18 358 1.0× 654 2.5× 69 1.0× 34 0.6× 55 1.1× 65 1.1k
N Saijo Japan 15 425 1.2× 531 2.0× 58 0.9× 21 0.4× 85 1.6× 48 877

Countries citing papers authored by Philippe Genne

Since Specialization
Citations

This map shows the geographic impact of Philippe Genne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Genne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Genne more than expected).

Fields of papers citing papers by Philippe Genne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Genne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Genne. The network helps show where Philippe Genne may publish in the future.

Co-authorship network of co-authors of Philippe Genne

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Genne. A scholar is included among the top collaborators of Philippe Genne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Genne. Philippe Genne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gobbo, Jessica, Isabelle Desmoulins, Marine Gilabert, et al.. (2022). OncoSNIPE® Study Protocol, a study of molecular profiles associated with development of resistance in solid cancer patients. BMC Cancer. 22(1). 41–41. 1 indexed citations
2.
Lemasson, Benjamin, Thomas Christen, Xavier Tizon, et al.. (2010). Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti‐angiogenic drug effects. NMR in Biomedicine. 24(5). 473–482. 33 indexed citations
3.
Bichat, Francis, Michel Demeule, Ben Lawrence, et al.. (2008). 139 POSTER Enhanced drug delivery to brain tumors with a new paclitaxel-peptide conjugate. European Journal of Cancer Supplements. 6(12). 45–45. 4 indexed citations
4.
Corcos, Laurent, et al.. (2005). A virus-directed enzyme prodrug therapy (VDEPT) strategy for lung cancer using a CYP2B6/NADPH-cytochrome P450 reductase fusion protein. Cancer Gene Therapy. 12(5). 497–508. 32 indexed citations
5.
Chauffert, Bruno, C. Duvillard, Francis Bichat, et al.. (2003). Rationale supporting the use of vasoconstrictors for intraperitoneal chemotherapy with platinum derivatives. Surgical Oncology Clinics of North America. 12(3). 835–848. 20 indexed citations
6.
Gourdeau, Henriette, Philippe Genne, Salam Kadhim, et al.. (2002). Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts. Cancer Chemotherapy and Pharmacology. 50(6). 490–496. 12 indexed citations
7.
Auvray, Pierrı̈ck, Francis Bichat, & Philippe Genne. (2000). Evaluation préclinique de l'activité antitumorale des inhibiteurs de l'aromatase. Bulletin du Cancer. 87(12). 7–22. 3 indexed citations
8.
Solary, Éric, Lionel Mannone, Denis Caillot, et al.. (2000). Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes. Leukemia. 14(12). 2085–2094. 20 indexed citations
9.
Dimanche‐Boitrel, Marie‐Thérèse, Olivier Micheau, Dennis S. France, et al.. (2000). P27KiP1 overexpression inhibits the growth and doxorubicin sensitivity of HT29 human colon cancer cells in vivo.. PubMed. 20(2A). 849–52. 6 indexed citations
10.
Garrido, Carmen, et al.. (1995). Circumvention of confluence‐dependent resistance in a human multi‐drug‐resistant colon‐cancer cell line. International Journal of Cancer. 61(6). 873–879. 22 indexed citations
11.
Eymin, Béatrice, Éric Solary, Sylvie Chevillard, et al.. (1995). Cellular pharmacology of azatoxins (topoisomerase‐II and tubulin inhibitors) in P‐glycoprotein‐positive and ‐negative cell lines. International Journal of Cancer. 63(2). 268–275. 14 indexed citations
12.
Assem, Mahfoud, Sylvie Bonvalot, Carmen Garrido, et al.. (1994). Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells. British Journal of Cancer. 70(4). 631–635. 16 indexed citations
13.
Dimanche‐Boitrel, Marie‐Thérèse, Philippe Genne, Olivier Duchamp, & Bruno Chauffert. (1994). Confluence dependent resistance (CDR) to doxorubicin and E-cadherin expression in murine mammary cells. Cancer Letters. 85(2). 171–176. 17 indexed citations
14.
Genne, Philippe, Olivier Duchamp, Denis Caillot, et al.. (1994). Preclinical study of cinchonine, a powerful MDR reversing agent. Anti-Cancer Drugs. 5. 23–23. 1 indexed citations
15.
Dimanche‐Boitrel, Marie‐Thérèse, Philippe Genne, Christian Le Grimellec, et al.. (1992). Confluence‐dependent resistance in human colon cancer cells: Role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells. International Journal of Cancer. 50(5). 677–682. 75 indexed citations
16.
Genne, Philippe, Anne Caignard, Rafaël Oriol, et al.. (1992). Histological reactivity of a monoclonal antibody against rat colon cancer cells on human and rat normal gut and colonic tumours. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 420(3). 233–242. 2 indexed citations
17.
Chauffert, Bruno, et al.. (1992). [Experimental chemotherapy of peritoneal carcinomatosis of colonic origin in rats].. PubMed. 16(3). 215–9. 12 indexed citations
18.
Caignard, Anne, Philippe Genne, Nils‐Olivier Olsson, Rafaël Oriol, & François Martin. (1990). F11C antigen: A membrane marker able to distinguish two regressive and progressive variants from a rat colon adenocarcinoma. International Journal of Cancer. 46(4). 633–639. 9 indexed citations
19.
Pelletier, H, J Millot, Bruno Chauffert, et al.. (1990). Mechanisms of resistance of confluent human and rat colon cancer cells to anthracyclines: alteration of drug passive diffusion.. PubMed. 50(20). 6626–31. 44 indexed citations
20.
Genne, Philippe, et al.. (1990). Serum concentrations of amiodarone required for an in vivo modulation of anthracycline resistance.. PubMed. 9(6). 1655–9. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda R. Barone Breakdown of academic impact, for papers by K H Cowan Breakdown of academic impact, for papers by Yue-Li Sun Breakdown of academic impact, for papers by Clifford Sachs Breakdown of academic impact, for papers by Svein A. Carlsen Breakdown of academic impact, for papers by Lee R. Tanzer Breakdown of academic impact, for papers by Gary L. Goldberg Breakdown of academic impact, for papers by Sakkaraiappan Ramalingam Breakdown of academic impact, for papers by Hisanobu Niitani Breakdown of academic impact, for papers by N Saijo
Rankless by CCL
2026